2008
DOI: 10.1016/j.jhsa.2008.01.001
|View full text |Cite
|
Sign up to set email alerts
|

A Prospective Randomized Controlled Trial of Injection of Dexamethasone Versus Triamcinolone for Idiopathic Trigger Finger

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
58
0
2

Year Published

2011
2011
2022
2022

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 72 publications
(63 citation statements)
references
References 23 publications
3
58
0
2
Order By: Relevance
“…2 The steroid (e.g., dexamethasone or triamcinolone) is typically mixed with a local anesthetic such as lidocaine. Aseptic technique is used to inject the steroid-lidocaine mixture into the flexor tendon sheath, at the midline of the flexor crease at the base of the digit.…”
Section: Injection Of Corticosteroid Is Generally Accepted As First-lmentioning
confidence: 99%
“…2 The steroid (e.g., dexamethasone or triamcinolone) is typically mixed with a local anesthetic such as lidocaine. Aseptic technique is used to inject the steroid-lidocaine mixture into the flexor tendon sheath, at the midline of the flexor crease at the base of the digit.…”
Section: Injection Of Corticosteroid Is Generally Accepted As First-lmentioning
confidence: 99%
“…Triggering may resolve after one or two corticosteroid injections, but the results vary substantially between studies (35 % and 87 % for one and 72 % to 92 % for two injections) [9][10][11][12][13]. Various literatures suggest that patients should be informed about 50% success rates when offering a corticosteroid injection for trigger finger and that the chances of patients landing to surgical release still remains [14][15][16]. Percutaneous release has a success rate of 94% according to a recent systematic review of 2114 procedures but is accompanied by relatively high rates of complications like injury to nerves, injury to A2 pulley and bowstringing [17].…”
Section: Introductionmentioning
confidence: 99%
“…[1] The aim of treatment is abolition of pain and restoration of a full range of smooth motion in the involved digit(s). [2] Current treatment options include either conservative management by splinting, [1] treatment with anti-inflammatory drugs or corticosteroid injection (usually with local anesthetic) in the flexor tendon sheath, [2][3][4][5][6][7][8][9][10] or surgical release of the A1 pulley (via an open or percutaneous approach). [11][12][13][14] Although there are no well controlled studies comparing treatment modalities, corticosteroid injection is widely accepted as first-line treatment of TF; surgery is generally reserved for cases of corticosteroid treatment failure or for patients with more severe articular locking and joint rigidity.…”
Section: Introductionmentioning
confidence: 99%
“…[11][12][13][14] Although there are no well controlled studies comparing treatment modalities, corticosteroid injection is widely accepted as first-line treatment of TF; surgery is generally reserved for cases of corticosteroid treatment failure or for patients with more severe articular locking and joint rigidity. [2,4,9,13] Certainly surgery is the definitive treatment, providing permanent resolution of symptoms, [4,13] but corticosteroid injection is often preferred, not only because a single injection is effective in a large proportion of patients, but also because it can be given in an office setting and is a relatively simple, low-cost procedure. [4] However, symptoms may not resolve with only one corticosteroid injection and the likelihood of success decreases with each subsequent injection (60% of 109 trigger digits after the first injection, 36% after the second, and 33% after the third; for those patients requiring more than one injection, average duration of relief from injection was 14 weeks, and ranged from 4 to 40 weeks).…”
Section: Introductionmentioning
confidence: 99%